A comprehensive view of u.s. food and drug administration (fda). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Dutch biotech firm UniQure’s Hemgenix injectable to treat hemophilia B, making it the first gene therapy treatment for the disorder; Australian drugmaker CSL has license for the treatment and places list price at US$3.5M
Published: November 23, 2022 by BioPharma Dive
InnerScope Hearing Technologies launches FDA-registered HearingAssist branded OTC hearing aids at RiteAid.com; the hearing aids range in price from US$499.99 to US$799.99 per pair complete with pocket-sized charging unit
Published: November 23, 2022 by Financial Services Monitor Worldwide
US Senator Mike Lee introduces proposal to end FDA biosimilar switching studies, make all approved biosimilars interchangeable; FDA has granted interchangeable status to only four of 39 biosimilars it has approved
Published: November 23, 2022 by FiercePharma
GlobalData: Continuous glucose monitoring devices could become main solution for US diabetes population if FDA's proposed changes to reimbursement go ahead; majority of diabetes patients currently have to undergo invasive self-testing several times a day
Published: November 22, 2022 by GlobalData Plc
Alliance Defending Freedom files suit against FDA, HHS to overturn FDA's approval of Mifeprex mifepristone abortion pill; NY Times reports abortion by medication accounts for half of abortions in US
Published: November 22, 2022 by FiercePharma

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count